A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 15671538
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with 68Ga-DOTATOC PET

  2004cited by this paper
• MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide.

  2004cited by this paper
• Christianity and Democracy: The Global Picture

  2004cited by this paper
• Epidemiology of prostate cancer.

  2003cited by this paper
• Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer.

  2003cited by this paper
• Novel Series of 111 In-Labeled Bombesin Analogs as Potential Radiopharmaceuticals for Specific Targeting of Gastrin-Releasing Peptide Receptors Expressed on Human Prostate Cancer Cells

  2003cited by this paper
• Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen.

  2003cited by this paper
• Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.

  2003cited by this paper
• 99mTc-bombesin detects prostate cancer and invasion of pelvic lymph nodes

  2003cited by this paper
• Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update.

  2003cited by this paper
• Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

  2003cited by this paper
• Peptide-PNA conjugates: targeted transport of antisense therapeutics into tumors.

  2003cited by this paper
• What's new in the treatment of advanced prostate cancer?

  2003cited by this paper
• Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells.

  2003cited by this paper
• Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.

  2003cited by this paper
• Perspectives of new potential therapeutic applications of somatostatin analogs.

  2003cited by this paper
• Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents.

  2003cited by this paper
• Direct selection of cDNAs from filamentous phage surface display libraries: potential and limitations.

  2002cited by this paper
• Antisense peptide nucleic acids conjugated to somatostatin analogs and targeted at the n-myc oncogene display enhanced cytotoxity to human neuroblastoma IMR32 cells expressing somatostatin receptors.

  2002cited by this paper
• Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

  2002cited by this paper
• Incidence rate and management of prostate carcinoma.

  2001cited by this paper
• Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.

  2001cited by this paper
• Cancer burden in the year 2000. The global picture.

  2001cited by this paper
• The use of phage display for the development of tumour targeting agents.

  2000cited by this paper
• Experience with carbon-11 choline positron emission tomography in prostate carcinoma

  2000cited by this paper
• Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238.

  2000cited by this paper
• High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers.

  2000cited by this paper
• Lipophilization of somatostatin analog RC‐160 with long chain fatty acid improves its antiproliferative and antiangiogenic activity in vitro

  2000cited by this paper
• NG2 proteoglycan-binding peptides target tumor neovasculature.

  1999cited by this paper
• Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

  1999cited by this paper
• Vascular targeting with phage peptide libraries.

  1999cited by this paper
• Tumor targeting with a selective gelatinase inhibitor

  1999cited by this paper
• Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread

  1999cited by this paper
• Delivery of molecular and cellular medicine to solid tumors.

  1998cited by this paper
• Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.

  1998cited by this paper
• Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

  1998cited by this paper
• Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma

  1998cited by this paper
• Prostate-specific membrane antigen expression in normal and malignant human tissues.

  1997cited by this paper
• Delivery of Molecular and Cellular Medicine to Solid Tumors

  1997cited by this paper
• Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium.

  1997cited by this paper
• Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone.

  1997cited by this paper
• Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose.

  1996cited by this paper
• Expression of the prostate-specific membrane antigen.

  1994cited by this paper
• Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.

  1987cited by this paper
• SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.

  1982cited by this paper
• Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

  1973cited by this paper
• Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes.

  1971cited by this paper
• Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the european amphibiansBombina andAlytes

  1971cited by this paper

• Nanotechnology Meets the Tumor Microenvironment: Unlocking New Horizons in Cancer Therapy.

  2025cites this paper
• Technetium-99m-labeled peptides and their applications in radio imaging: advancements in Latin American research

  2024cites this paper
• Smart nanoparticles for cancer therapy

  2023cites this paper
• RNA aptamer-mediated gene therapy of prostate cancer: lessons from the past and future directions

  2023cites this paper
• The Use of Phage Antibodies for Microbial Cells Detection (Review)

  2023cites this paper
• Recombinant antibodies by phage display for bioanalytical applications.

  2022cites this paper
• The Use of Phage Antibodies for Microbial Cell Detection

  2022cites this paper
• Ligand engineering for theranostic applications.

  2021cites this paper
• Nanobodies Targeting Prostate-Specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer

  2020cites this paper
• A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (−) prostate cancer specific therapy

  2019cites this paper
• Combination of metformin and paclitaxel suppresses proliferation and induces apoptosis of human prostate cancer cells via oxidative stress and targeting the mitochondria-dependent pathway

  2019cites this paper
• Aptamers: Biotechnological Applications of a Next Generation Tool

  2019cites this paper
• Phage Display Libraries: From Binders to Targeted Drug Delivery and Human Therapeutics

  2019cites this paper
• Aptamer: Apt System for Target-Specific Drug Delivery

  2019cites this paper
• Polymer Nanoplatforms at Work in Prostate Cancer Therapy

  2019cites this paper
• Identification of a Novel Tumor-Binding Peptide for Lung Cancer Through in-vitro Panning

  2018cites this paper
• Antibody Engineering for Pursuing a Healthier Future

  2017cites this paper
• Identification of Ligands and Translation to Clinical Applications

  2017cites this paper
• Versatile Chemical Derivatizations to Design Glycol Chitosan-Based Drug Carriers

  2017cites this paper
• Novel peptide probes to assess the tensional state of fibronectin fibers in cancer

  2017cites this paper
• Microfluidics in the selection of affinity reagents for the detection of cancer: paving a way towards future diagnostics.

  2016cites this paper
• Study on the relationship between the structure and functions of anti-human cervical cancer single-chain antibody and the lengths of linkers.

  2016cites this paper
• DUP1 peptide modified micelle efficiently targeted delivery paclitaxel and enhance mitochondrial apoptosis on PSMA-negative prostate cancer cells

  2016cites this paper
• Targeting Tumors with Small Molecule Peptides.

  2016cites this paper
• Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system.

  2016cites this paper
• Insights into pathological extracellular matrix by non-invasive nuclear imaging with fibronectin-binding peptide A5 and FGF-2

  2016cites this paper
• Proteomics and Prostate Cancer

  2015cites this paper
• Isolation And Studying of Specificity of Bacteriophages Binding To Murine Lung Adenocarcinoma

  2015cites this paper
• In Vitro Selection of Cancer Cell-Specific Molecular Recognition Elements from Amino Acid Libraries

  2015cites this paper
• Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics.

  2014influential citation
• Ultra-effective photothermal therapy for prostate cancer cells using dual aptamer-modified gold nanostars.

  2014cites this paper
• Mechanistic and high-throughput approaches for the design of molecular imaging probes and targeted therapeutics

  2014cites this paper
• DNA aptamer-based detection of prostate cancer

  2014cites this paper
• Combinatorial peptide libraries: mining for cell-binding peptides.

  2014cites this paper
• Investigations in Molecular Recognition Element Selection and Single-Wall Carbon Nanotube Properties

  2013cites this paper
• From peptides to small molecules: an intriguing but intricated way to new drugs.

  2013cites this paper
• Nanomaterials design and tests for neural tissue engineering.

  2013cites this paper
• PEGylation enables the specific tumor accumulation of a peptide identified by phage display.

  2013cites this paper
• Phage display—A powerful technique for immunotherapy

  2012cites this paper
• A highly entangled polymeric nanoconstruct assembled by siRNA and its reduction-triggered siRNA release for gene silencing.

  2012cites this paper
• Comparison of two peptide radiotracers for prostate carcinoma targeting

  2012influential citation
• Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates.

  2012cites this paper
• Development of molecular techniques for imaging and treatment of tumors.

  2011cites this paper
• Techniques for Molecular Imaging Probe Design

  2011cites this paper
• Facile method for development of ligand-patterned substrates induced by a chemical reaction.

  2011cites this paper
• Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (-) prostate cancers.

  2011cites this paper
• Tumor-targeted drug delivery with aptamers.

  2011cites this paper
• Biotechnology techniques for the development of new tumor specific peptides.

  2011cites this paper
• A Fully Synthetic "Phage-Like" System II: Synthesis and Live Cell Screening of Combinatorial Libraries of Peptides on Sub-Cellular Sized Microspheres

  2011cites this paper
• Challenges in Optimizing a Prostate Carcinoma Binding Peptide, Identified through the Phage Display Technology

  2011cites this paper
• Identification of a New Peptide for Fibrosarcoma Tumor Targeting and Imaging In Vivo

  2010cites this paper
• Sunflower Trypsin Inhibitor 1 Derivatives as Molecular Scaffolds for the Development of Novel Peptidic Radiopharmaceuticals

  2010cites this paper
• Targeted Drug Delivery to Hepatocarcinoma In vivo by Phage-Displayed Specific Binding Peptide

  2010cites this paper
• The synergistic use of computation, chemistry and biology to discover novel peptide-based drugs: the time is right.

  2010cites this paper
• Fully synthetic phage-like system for screening mixtures of small molecules in live cells.

  2010cites this paper
• Phage display in molecular imaging and diagnosis of cancer.

  2010cites this paper
• Positron emission tomography imaging of prostate cancer

  2010cites this paper
• Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets.

  2010cites this paper
• Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.

  2010cites this paper
• Simultaneous electrochemical detection of both PSMA (+) and PSMA (-) prostate cancer cells using an RNA/peptide dual-aptamer probe.

  2010cites this paper
• Targeting vault nanoparticles to specific cell surface receptors.

  2009cites this paper
• Darwinian molecular imaging

  2009cites this paper
• Gamma scintigraphy imaging of murine invasive pulmonary aspergillosis with a (111)In-labeled cyclic peptide.

  2009cites this paper
• Prostate cancer cell–specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes

  2009cites this paper
• A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides.

  2008cites this paper
• Endoradiotherapy with peptides - status and future development.

  2008cites this paper
• Phage peptide display.

  2008cites this paper
• Screening and identification of a novel hepatocellular carcinoma cell binding peptide by using a phage display library

  2008cites this paper
• Screening and identification of a novel hepatocellular carcinoma cell binding peptide by using a phage display library

  2008cites this paper
• Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery

  2008cites this paper
• Targeting Phosphatidylserine on Apoptotic Cells with Phages and Peptides Selected from a Bacteriophage Display Library

  2007cites this paper
• Potential of phage-displayed peptide library technology to identify functional targeting peptides

  2007cites this paper
• Influence of Chelate Conjugation on a Newly Identified Tumor-Targeting Peptide

  2007cites this paper
• Radiolabeled peptides and proteins in cancer therapy.

  2007cites this paper
• Bacteriophage biopanning in human tumour biopsies to identify cancer-specific targeting ligands

  2007cites this paper
• From combinatorial chemistry to cancer-targeting peptides.

  2007cites this paper
• Identification of a Met-Binding Peptide from a Phage Display Library

  2007cites this paper
• Identification of aMet-Binding Peptide from a Phage Display Library

  2007cites this paper
• Genomics und Proteomics in der Nuklearmedizin

  2007cites this paper
• Identification of cancer targets and therapeutics using phage display.

  2006cites this paper
• In vivo imaging of molecularly targeted phage.

  2006cites this paper
• Annual Congress of the European Association of Nuclear Medicine

  2006cites this paper
• In Vivo Phage Display Selection Yields Atherosclerotic Plaque Targeted Peptides for Imaging

  2006cites this paper
• High-throughput Identification of Phage-derived Imaging Agents

  2006cites this paper
• Isolation of multiple cell-binding ligands from different phage displayed-peptide libraries.

  2006cites this paper
• Characterization and development of a peptide (p160) with affinity for neuroblastoma cells.

  2006cites this paper
• The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs

  2006cites this paper
• Modulation of tracer accumulation in malignant tumors: gene expression, gene transfer, and phage display.

  2005cites this paper
• Einfluss molekularbiologischer Verfahren auf nuklearmedizinische Methoden

  2005cites this paper
• Molecular imaging and therapy—a programme based on the development of new biomolecules

  2005cites this paper
• International Journal of Nanomedicine Dovepress Novel Peptide–dendrimer Conjugates as Drug Carriers for Targeting Nonsmall Cell Lung Cancer

  year unknowncites this paper